SPAC Bubble of 2020–2021

The SPAC bubble of 2020–2021 was a frenzy of blank-check company formation and merger activity that flooded public markets with hundreds of shell corporations backed by celebrity endorsements and promises of transformative businesses. Despite the euphoria, the vast majority of deals failed to deliver returns, making the period a textbook example of how low interest rates, retail investor enthusiasm, and regulatory latitude can inflate speculative excess into a systemic distortion.

How a shell becomes a unicorn

A special-purpose-acquisition-company is a blank-check corporation created solely to raise capital and acquire an existing private business, thereby taking it public without a traditional initial-public-offering. Structurally, SPACs are not new; they have existed since the 1980s. What changed in 2020 was the sheer volume, the celebrity involvement, and the speed with which investors funnelled capital into vehicles with no announced targets.

The attraction was obvious. SPACs offered a faster, cheaper path to public markets than traditional IPOs. Sponsor teams would form a shell, raise capital (typically $200 million to $1 billion), and then hunt for a merger target. Shareholders in the SPAC received units containing shares and warrants, structures that made the mathematics of “returns” appear generous on paper.

By mid-2020, with the Federal Reserve having slashed interest-rate to near-zero after the COVID-19 shock, capital was abundant and desperately seeking yield. Retail investors, energised by lockdowns and stimulus cheques, poured money into trendy themes: electric vehicles, cannabis, cryptocurrency, biotechnology, real-estate innovation. SPACs became the vehicle of choice because they promised direct exposure to “the next unicorn” at ground-floor valuations.

The celebrity-and-momentum phase

The bubble inflated as high-profile backers lent their names to new SPACs. Professional athletes, entertainment figures, and former government officials raised capital by mere association. The pitch was simple: “I’m backing a team that will find the next Tesla or Airbnb.” Retail investors competed for allocation in hot SPAC IPOs, driving valuations higher. Several blank-check vehicles rocketed 50–100% in their first weeks of trading, purely on speculation that the sponsor’s reputation guaranteed a good target.

Merger announcements unleashed even more enthusiasm. When a SPAC publicly declared its target—often a privately held startup with impressive-sounding business model—both the SPAC’s shares and the startup’s equity (held by venture investors) would typically spike. The SPAC announced merger valuations that were wildly generous, reflecting both the scarcity of attractive public offerings and the euphoria around growth themes.

A few examples illustrate the excess. Nikola, a hydrogen truck startup, went public via a SPAC merger at a multi-billion-dollar valuation despite no revenue and later-revealed fraud in its prototype demonstrations. Lordstown Motors, a legacy-auto plant attempting electric vehicles, faced similar capital destruction. Numerous “blank-check clinical-stage biotech” SPACs raised capital on vague drug-development promises and went to zero.

The illusion of valuation

A critical flaw in the SPAC structure was the illusion that market-determined pricing equated to rigorous valuation. When a SPAC traded at $10 per share (typical for freshly listed shells), investors assumed that represented fair value. When a merger was announced at, say, a $5 billion valuation for a target company, that figure was treated as discovered truth by the market. In reality, both were expressions of demand from retail speculators with no fundamental analysis—just momentum-chasing and theme exposure.

Sponsors and investment banks profited handsomely. Sponsors retained 20% of the post-merger equity (“founder shares”) essentially free, while underwriting banks collected fees for the SPAC IPO and then again for the merger advisory. There was zero misalignment of incentives on the upside: everyone involved in the SPAC formation had already won the moment the shell listed, regardless of whether the merger target ever created value.

Institutional investors, initially sceptical, began allocating to SPACs as underperformance vs. the market became untenable. Late money chased performance, pushing the bubble into its final, most unstable phase in late 2020 and early 2021.

Collapse and aftermath

Sentiment shifted sharply in mid-2021. The Federal Reserve began signalling interest-rate increases. Stock markets stumbled on inflation concerns. Retail investor enthusiasm waned as lockdowns ended and stimulus cheques ceased. SPAC IPO issuance slowed dramatically.

More damaging were the disclosures from the earliest mergers. The stocks of most completed deals underperformed the broader market. Nikola faced criminal charges. Several SPACs saw sponsor founder shares diluted or redeemed in down markets. Retail investors who had chased 100% IPO pops discovered that the $10 unit was fair value and likely a poor entry point.

By 2022, the SPAC craze had evaporated. Of the hundreds of SPACs formed in 2020–2021, a large majority either failed to complete a merger (returning capital and admitting defeat) or merged into targets whose stocks subsequently cratered. Estimates suggest that only a handful of the several hundred mergers generated positive returns for public shareholders.

Why SPACs matter as a cautionary lesson

The SPAC bubble illustrates how regulatory arbitrage, financial engineering, and asymmetric incentives can create explosive misallocation of capital. A SPAC is fundamentally a mechanism by which sponsors and venture investors can exit at peak valuations by transferring risk to retail public-market investors. The structure itself—blank cheque, deferred merger, founder compensation in free shares—is designed to reward the insiders regardless of outcome.

The frenzy was enabled by ultra-low interest-rate that made return-seeking capital desperate, and by permissive Securities and Exchange Commission rule-making that treated SPAC merger announcements almost as lightly as traditional disclosures. Had rates been higher and scrutiny stricter, the excesses would have been muted.

The bubble also exposed the limits of retail investor sophistication. SPAC marketing leaned heavily on hype and celebrity, not analysis. Many retail buyers treated them like lottery tickets rather than equity ownership stakes. When the music stopped, they bore the loss while the sponsors and venture investors had already extracted their gains.

See also